Inventor · disambiguated record
Jessica Flechtner
Also filed as: FLECHTNER JESSICA · FLECHTNER JESSICA BAKER
13 granted patents·8 pending applications·65 citations·filing 2004–2020
90Inventor score
Top patents by PatentIndex Score
21 records- 0195US9873870B2Antigen screening systemGENOCEA BIOSCIENCES INC·Filed 2015·Granted Jan 23, 2018·9 cites·38 claims
- 0290US9045791B2Antigen screening systemGENOCEA BIOSCIENCES INC·Filed 2012·Granted Jun 2, 2015·7 cites·23 claims
- 0390US8617564B2Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune responseLONG DEBORAH·Filed 2010·Granted Dec 31, 2013·12 cites·30 claims
- 0488US8313894B2Antigen screening systemFLECHTNER JESSICA·Filed 2009·Granted Nov 20, 2012·15 cites·65 claims
- 0583US10570387B2Antigen screening systemGENOCEA BIOSCIENCES INC·Filed 2017·Granted Feb 25, 2020·1 cites·20 claims
- 0681US9895436B2Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune responseGENOCEA BIOSCIENCES INC·Filed 2013·Granted Feb 20, 2018·2 cites·69 claims
- 0780US10859566B2Treatment methodsGENOCEA BIOSCIENCES INC·Filed 2018·Granted Dec 8, 2020·4 cites·26 claims
- 0880US7309491B2Heat shock protein-based vaccines and immunotherapiesANTIGENICS INC·Filed 2004·Granted Dec 18, 2007·11 cites·47 claims
- 0976US9782474B2Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune responseLONG DEBORAH·Filed 2011·Granted Oct 10, 2017·2 cites·36 claims
- 1075US9624273B2Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune responseGENOCEA BIOSCIENCES INC·Filed 2012·Granted Apr 18, 2017·2 cites·35 claims
- 1172US11162093B2Antigen screening systemGENOCEA BIOSCIENCES INC·Filed 2020·Granted Nov 2, 2021·0 cites·41 claims
- 1267US10653771B2Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune responseGENOCEA BIOSCIENCES INC·Filed 2018·Granted May 19, 2020·0 cites·21 claims
- 1358US9765125B2Fused antigen vaccines and compositions against Streptococcus pneumoniaeGENOCEA BIOSCIENCES INC·Filed 2013·Granted Sep 19, 2017·0 cites·20 claims
- 1455US2021199644A1Treatment methodsGENOCEA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1546US2012135025A1Chlamydia antigens and uses thereofFLECHTNER JESSICA BAKER·Filed 2011·Application pending·0 cites
- 1645US2011293664A1Chlamydia antigens and uses thereofCOHANE KENYA·Filed 2009·Application pending·0 cites
- 1744US2017043005A1Chlamydia antigens and uses thereofGENOCEA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 1843US2023041057A1Treatment methodsGENOCEA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1943US2023057310A1Treatment methodsGENOCEA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 2043US2022211832A1Treatment methodsGENOCEA BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 2142US2022412979A1Treatment methodsGENOCEA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jessica Flechtner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →